Cargando…

Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”

Detalles Bibliográficos
Autores principales: Eldani, Céline, Darrigade, Anne Sophie, Beylot-Barry, Marie, Jullie, Marie-Laure, Ducharme, Océane, Milpied, Brigitte, Pham-Ledard, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Libbey Eurotext 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195128/
https://www.ncbi.nlm.nih.gov/pubmed/36856394
http://dx.doi.org/10.1684/ejd.2022.4378
_version_ 1785044159007031296
author Eldani, Céline
Darrigade, Anne Sophie
Beylot-Barry, Marie
Jullie, Marie-Laure
Ducharme, Océane
Milpied, Brigitte
Pham-Ledard, Anne
author_facet Eldani, Céline
Darrigade, Anne Sophie
Beylot-Barry, Marie
Jullie, Marie-Laure
Ducharme, Océane
Milpied, Brigitte
Pham-Ledard, Anne
author_sort Eldani, Céline
collection PubMed
description
format Online
Article
Text
id pubmed-10195128
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Libbey Eurotext
record_format MEDLINE/PubMed
spelling pubmed-101951282023-05-19 Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like” Eldani, Céline Darrigade, Anne Sophie Beylot-Barry, Marie Jullie, Marie-Laure Ducharme, Océane Milpied, Brigitte Pham-Ledard, Anne Eur J Dermatol Correspondence John Libbey Eurotext 2023-05-18 2022 /pmc/articles/PMC10195128/ /pubmed/36856394 http://dx.doi.org/10.1684/ejd.2022.4378 Text en © JLE/Springer 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Eldani, Céline
Darrigade, Anne Sophie
Beylot-Barry, Marie
Jullie, Marie-Laure
Ducharme, Océane
Milpied, Brigitte
Pham-Ledard, Anne
Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
title Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
title_full Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
title_fullStr Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
title_full_unstemmed Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
title_short Successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
title_sort successful rechallenge for severe lichenoid drug reaction to pembrolizumab presenting as “toxic epidermal necrolysis-like”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10195128/
https://www.ncbi.nlm.nih.gov/pubmed/36856394
http://dx.doi.org/10.1684/ejd.2022.4378
work_keys_str_mv AT eldaniceline successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike
AT darrigadeannesophie successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike
AT beylotbarrymarie successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike
AT julliemarielaure successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike
AT ducharmeoceane successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike
AT milpiedbrigitte successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike
AT phamledardanne successfulrechallengeforseverelichenoiddrugreactiontopembrolizumabpresentingastoxicepidermalnecrolysislike